EP2773316A2 - Émulsions eau-dans-huile cosmétiques ou dermatologiques présentant une teneur en urée et en polyglycéryl-4 diisostéarate/polyhydroxystéarate/sébacate - Google Patents
Émulsions eau-dans-huile cosmétiques ou dermatologiques présentant une teneur en urée et en polyglycéryl-4 diisostéarate/polyhydroxystéarate/sébacateInfo
- Publication number
- EP2773316A2 EP2773316A2 EP12778732.3A EP12778732A EP2773316A2 EP 2773316 A2 EP2773316 A2 EP 2773316A2 EP 12778732 A EP12778732 A EP 12778732A EP 2773316 A2 EP2773316 A2 EP 2773316A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- cosmetic
- polyglyceryl
- diisostearate
- urea
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 239000004202 carbamide Substances 0.000 title claims abstract description 24
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 239000000839 emulsion Substances 0.000 title claims abstract description 13
- 229940116351 sebacate Drugs 0.000 title claims abstract description 12
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims description 30
- 239000006210 lotion Substances 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 239000007762 w/o emulsion Substances 0.000 description 4
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- -1 glyceryl glucose Chemical compound 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 244000165918 Eucalyptus papuana Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 241001134446 Niveas Species 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical class OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to cosmetic or dermatological water-in-oil emulsions containing urea and polyglyceryl-4 diisostearate / polyhydroxystearate / sebacate.
- Urea is considered in about 2% preparations as granulation (as granulation tissue is called the typical young, vascular-rich connective tissue, which is formed in the wound and ulcer healing or in chronic inflammation and after some time in scar tissue is transformed).
- the dermatologist makes use of the hygroscopic (hydrophilic) effect of the urea, e.g. in the treatment of ichthyosis ("fish scale disease"), psoriasis and atopic dermatitis.
- Hygroscopic substances primarily urea, retain moisture in the cornea as a natural moisturizing factor. If the water content in the horny layer (caused by urea deficiency) falls below 15%, e.g. In atopic eczema, the skin becomes dry, brittle and cracked. Similar to atopic dermatitis, psoriasis also lacks urea in the epidermis. The result is a strong dehydration of the affected skin areas.
- urea In cosmetic skin preparations, urea is used as a substance that binds moisture in the skin (1 to 2%). A 10% aqueous solution of urea is bactericidal. After all, urea - which can be used both in pharmacy and cosmetics - has a keratolytic or keratoplastic effect (has a softening effect on the keratin of the skin) as well as relieves itching. Due to its polar structure, it holds the water in the skin and thereby keeps it smoothness and suppleness.
- the effect of the active ingredient allantoin is also based on urea, as it is split off from the allantoin.
- the problem is that just natural oils in combination with urea are difficult to formulate.
- ethoxylated emulsifiers For the development of stable water-in-oil emulsions, ethoxylated emulsifiers have always had to be resorted to. As a result, it is often necessary to add sensory additives to the product in order to achieve a pleasant sensory perception of the product, since ethoxylated compounds tend to impart some tackiness to the cosmetic formulation.
- the object of the present invention was to eliminate the disadvantages of the prior art.
- the object is achieved by cosmetic or dermatological water-in-oil emulsions containing
- Polyglyceryl-4 diisostearate / polyhydroxystearate / sebacate is characterized by an approximate structural element as follows
- R 1 COO, R 2 COO and R 3 COO can independently of one another be isostearate and / or polyhydoxystearate, and n assumes values of about 2 to 3.
- the molar ratio of polyhydroxystearate to isostearate should be about 1: 2.
- the prior art discloses W / O emulsions with 5% urea, based on or ethyoxylated emulsifiers. These preparations are unstable with very high urea concentration (> 5%) or extremely viscous and therefore very sticky.
- the weight ratio of urea on the one hand Polyglyceryl-4 diisostearate / polyhydroxystearates / sebacate on the other hand from the range of 100: 1 to 1 to 100, preferably 10: 1 to 1 to 10, particularly preferably 2: 1 to 1: 2.
- Cosmetic or dermatological preparations according to the invention advantageously contain 0.01 to 60 wt .-%, preferably 0.1 to 25 wt .-%, particularly preferably 1 to 10 wt .-% of urea, based on the total weight of the preparations.
- Cosmetic or dermatological preparations according to the invention advantageously contain 0.0001 to 15 wt .-%, preferably 0.01 to 10 wt .-%, particularly preferably 0.05 to 2.5 wt .-% of polyglyceryl-4 diisostearate / polyhydroxystearates / Sebacate, based on the total weight of the preparations.
- the cosmetic and dermatological preparations are applied according to the invention in the usual manner for cosmetics on the skin and / or hair in sufficient quantity.
- the cosmetic and dermatological preparations according to the invention may contain cosmetic or galenic adjuvants such as are commonly used in such preparations, e.g. Preservatives, bactericides, perfumes, foaming inhibitors, dyes, pigments having a coloring effect, thickeners, moisturizing and / or moisturizing substances, fats, oils, waxes or other common ingredients of a cosmetic or dermatological formulation such as alcohols, polyols, Polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
- cosmetic or galenic adjuvants such as are commonly used in such preparations, e.g. Preservatives, bactericides, perfumes, foaming inhibitors, dyes, pigments having a coloring effect, thickeners, moisturizing and / or moisturizing substances, fats, oils, waxes or other common ingredients of a cosmetic or dermatological formulation such as alcohols, polyols, Polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
- antioxidants which are suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants.
- the amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30 wt .-%, particularly preferably 0.05 to 20 wt .-%, in particular 1-10 wt .-%, based on the total weight of Preparation.
- the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, it is possible to use as solvent: Water or aqueous solutions
- Oils such as triglycerides of capric or caprylic acid, but preferably castor oil; Fats, waxes and other natural and synthetic fats, preferably esters of fatty acids with lower C-number alcohols, e.g. with isopropanol, propylene glycol or glycerol, glyceryl glucose, NMF complex, ceramides, cholesterol, sterols or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids; Alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products.
- Fats, waxes and other natural and synthetic fats preferably
- mixtures of the abovementioned solvents are used.
- alcoholic solvents water can be another ingredient.
- the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, it is possible to use as solvent:
- Oils such as triglycerides of capric or caprylic acid, but preferably castor oil; Fats, waxes and other natural and synthetic fats, preferably esters of fatty acids with lower C-number alcohols, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids;
- Alcohols, diols or polyols of low C number, and their ethers preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products.
- mixtures of the abovementioned solvents are used.
- alcoholic solvents water can be another ingredient.
- Suitable propellants for sprayable from aerosol containers cosmetic and / or dermatological preparations in the context of the present invention the usual known volatile, liquefied propellants, such as hydrocarbons (propane, butane, isobutane) are suitable, which can be used alone or in mixture with each other. Also, compressed air is advantageous to use.
- hydrocarbons propane, butane, isobutane
- compressed air is advantageous to use.
- propellants which would be useful in the practice of the present invention in the form of aerosol preparations, but which should be avoided due to adverse environmental effects or other concomitant conditions, especially fluorocarbons and chlorofluorocarbons (US Pat. CFC).
- Cosmetic preparations in the context of the present invention may also be present as gels which, in addition to an effective content of the active ingredient according to the invention and solvents customarily used for it, preferably water, also organic thickening agents, e.g. Gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose or inorganic thickening agents, e.g. For example, aluminum silicates such as bentonites, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate.
- the thickener is present in the gel e.g. in an amount between 0, 1 and 30 wt .-%, preferably between 0.5 and 15 wt .-%, included.
- the preparations may advantageously contain further substances which absorb UV radiation in the UVB range, the total amount of filter substances being e.g. 0, 1 wt .-% to 30 wt .-%, preferably 0.5 to 10 wt .-%, in particular 1 to 6 wt .-%, based on the total weight of the preparations in order to provide cosmetic preparations, which protect the skin from the entire range of ultraviolet radiation. They can also serve as sunscreen.
- the total amount of filter substances being e.g. 0, 1 wt .-% to 30 wt .-%, preferably 0.5 to 10 wt .-%, in particular 1 to 6 wt .-%, based on the total weight of the preparations in order to provide cosmetic preparations, which protect the skin from the entire range of ultraviolet radiation. They can also serve as sunscreen.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201110085535 DE102011085535A1 (de) | 2011-11-01 | 2011-11-01 | Kosmetische oder dermatologische Wasser–in–Öl-Emulsionen mit einem Gehalt anHarnstoff und Polyglyceryl-4 Diisostearat/Polyhydroxystearat/Sebacat. |
| PCT/EP2012/071282 WO2013064432A2 (fr) | 2011-11-01 | 2012-10-26 | Émulsions eau-dans-huile cosmétiques ou dermatologiques présentant une teneur en urée et en polyglycéryl-4 diisostéarate/polyhydroxystéarate/sébacate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2773316A2 true EP2773316A2 (fr) | 2014-09-10 |
Family
ID=47080521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12778732.3A Ceased EP2773316A2 (fr) | 2011-11-01 | 2012-10-26 | Émulsions eau-dans-huile cosmétiques ou dermatologiques présentant une teneur en urée et en polyglycéryl-4 diisostéarate/polyhydroxystéarate/sébacate |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2773316A2 (fr) |
| DE (1) | DE102011085535A1 (fr) |
| WO (1) | WO2013064432A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3112286B1 (fr) * | 2020-07-10 | 2023-02-24 | Oreal | Emulsion eau dans huile à haute teneur en phase interne aqueuse |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10333443A1 (de) | 2003-07-23 | 2005-02-10 | Goldschmidt Ag | Emulgator für dünnflüssige W/O-Emulsionen auf Basis von teilvernetzten Polyglycerinestern der Polyhydroxystearinsäure |
| DE102007005186A1 (de) * | 2007-01-29 | 2008-07-31 | Merck Patent Gmbh | Partikuläres UV-Schutzmittel |
| DE102008028821A1 (de) * | 2007-06-20 | 2009-01-29 | Henkel Ag & Co. Kgaa | Kosmetischer Stift auf Basis einer verdickten Öl-in-Wasser-Dispersion/Emulsion |
| EP2234578B1 (fr) * | 2007-12-20 | 2015-10-21 | L'Oréal | Émulsion huileuse stabilisée avec un émulsifiant lipophile et un polysaccharide hydrophobiquement modifié |
| DE102009002417A1 (de) * | 2009-04-16 | 2010-10-21 | Evonik Goldschmidt Gmbh | Verwendung organomodifizierter, im Siliconteil verzweigter Siloxane zur Herstellung kosmetischer oder pharmazeutischer Zusammensetzungen |
-
2011
- 2011-11-01 DE DE201110085535 patent/DE102011085535A1/de not_active Withdrawn
-
2012
- 2012-10-26 WO PCT/EP2012/071282 patent/WO2013064432A2/fr not_active Ceased
- 2012-10-26 EP EP12778732.3A patent/EP2773316A2/fr not_active Ceased
Non-Patent Citations (4)
| Title |
|---|
| DATABASE GNPD [online] MINTEL; 21 January 2011 (2011-01-21), ANONYMOUS: "Foot & Heel Cream", XP055608883, retrieved from www.gnpd.com Database accession no. 1467814 * |
| DATABASE GNPD [online] MINTEL; 6 February 2009 (2009-02-06), ANONYMOUS: "Pro Collagen Intensive Cream", XP055608880, retrieved from www.gnpd.com Database accession no. 1044585 * |
| MEYER J ET AL: "A novel PEG-free emulsifier designed for formulating W/O lotions with a light skin feel", SOFW-JOURNAL SEIFEN, OELE, FETTE, WACHSE, VERLAG FUR CHEMISCHE INDUSTRIE, AUGSBURG, DE, vol. 131, no. 11, 1 January 2005 (2005-01-01), pages 20 - 28, XP009104229, ISSN: 0942-7694 * |
| See also references of WO2013064432A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013064432A3 (fr) | 2014-04-24 |
| DE102011085535A1 (de) | 2013-05-02 |
| WO2013064432A2 (fr) | 2013-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2020221B1 (fr) | DMS (Derma Membrane Structure) dans des crèmes moussantes | |
| EP1992323B1 (fr) | Formulations mousseuses sans tensioactif | |
| EP2335675B1 (fr) | Formules de mousse sans émulsifiant et stabilisées par polymères | |
| EP2238977A2 (fr) | Produit de soin de la peau | |
| EP2029089B1 (fr) | Émulsion h/e pour le soin de la main | |
| EP2701671B1 (fr) | CONCENTRE D'UNE OW EMULSION, PROCES POUR SA FABRICATION ET& xA;PRODUIT DE BEAUTE POUR LA PEAU CONTENANT CE CONCENTRE | |
| WO2009115164A2 (fr) | Préparations cosmétiques ou dermatologiques rafraîchaissantes ayant une teneur en (1r,2s,5r)-2-isopropyl-5-méthyl-n-(2-(pyridyn-2-yl)éthyl-cyclohexancarboxamide et/ou en (1r,2s,5r)-n-(4-(cyanométhyl)phényl)-2-isopropyl-5- méthylcyclohexancarboxamide et en menthoxypropandiol | |
| WO2010009809A2 (fr) | Combinaisons de principes actifs constituées d'extrait de fruits d'anis et d'acide hyaluronique | |
| EP3883534B1 (fr) | Préparation de soins du visage contenant de l'huile | |
| WO2012031987A2 (fr) | Dihydrochlorure d'octénidine utilisé comme co-émulsifiant dans des microémulsions | |
| EP2654699B1 (fr) | Combinaisons de principes actifs constituées de glucosylglycérides et d'un ou de plusieurs conservateurs | |
| KR102248067B1 (ko) | 화장료 조성물 | |
| DE102005023639A1 (de) | Wirkstoffkombinationen aus Glucosylglyceriden, oberflächenaktiven Glucosederivaten und Oligoglycerinderivaten | |
| EP2773316A2 (fr) | Émulsions eau-dans-huile cosmétiques ou dermatologiques présentant une teneur en urée et en polyglycéryl-4 diisostéarate/polyhydroxystéarate/sébacate | |
| EP2695599A1 (fr) | Préparations cosmétiques ou dermatologiques ayant une teneur en urée et une teneur en Licochalcone A ou un extrait aqueux de Radix Glycyrrhizae inflatae, contenant de la Licochalcone A | |
| DE19618809C1 (de) | Kosmetisches Mittel | |
| EP1885328B1 (fr) | Combinaisons de matieres actives formees de glycerides de glucosyle et de creatine et/ou de creatinine | |
| EP2384738B1 (fr) | Utilisation d'esters salicyliques pour le masquage d'odeur de produits de dégradation de l'urée | |
| DE102010055770A1 (de) | Verfahren zur Herstellung kosmetischer und/oder dermatologischer Emulsionen mit einem oder mehreren Glucosylglyceriden | |
| DE102005051862A1 (de) | Emulsion enthaltend 1,2-Alkandiole und polare Ölkomponenten | |
| KR100681704B1 (ko) | 지방산 및 셀룰로오스 알킬 에테르를 유효성분으로함유하는 유중수형 화장료 조성물 | |
| DE19625095C1 (de) | Kosmetisches Mittel | |
| DE29611013U1 (de) | Kosmetisches Mittel | |
| WO2021032700A1 (fr) | Émulsion ew cosmétique contenant du succinoglucane | |
| EP4346770A1 (fr) | Compositions contenant des substances formant membrane pour la production d'une mousse formée par pompage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140424 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| R17P | Request for examination filed (corrected) |
Effective date: 20141029 |
|
| RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20170406 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
| 18R | Application refused |
Effective date: 20200424 |